Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/23332
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNikolić, Milica-
dc.contributor.authorGeroski, Tijana-
dc.contributor.authorFilipovic, Nenad-
dc.date.accessioned2026-10-01T10:26:36Z-
dc.date.available2026-10-01T10:26:36Z-
dc.date.issued2026-
dc.identifier.isbn978-961-7238-16-7en_US
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/23332-
dc.descriptionAbstracten_US
dc.description.abstractIn this research, we created a QSAR framework to analyse drug safety with the purpose of generating interpretable and relevant SSbD insights. We used public database containing approximately 20 000 brightfield microscopy images of human liver spheroids exposed to 108 drugs over a period of up to 7 days. [1] CellProfiler open-source software was used to perform image segmentation and extract features related to spheroid size, shape, intensity and texture. These features were extracted from each image and exported into a CSV file, which served as input to the QSAR framework. The CSV file was further enriched with molecular fingerprints and physicochemical descriptors generated by RDKit library. [2] We utilised scikit-learn library to train a Random Forest model, perform cross-validation and select the most relevant features. A simpler linear model was developed to compare interpretability against Random Forest model. The QSAR model investigated how the drug structure links to developed spheroid phenotype, that links to toxicity prediction. We interpreted the QSAR results using SHAP values, to identify key structural features which were further analysed in an open-source OECD QSAR Toolbox to provide mechanistic context and support grouping of compounds in line with the SSbD principles. The final output from this research is to derive conclusions of drug safety to the liver human spheroids based on correlation between chemical and structural composition of applied drugs and observed changes in spheroids upon exposure, leading to design-relevant insights, where specific aspects of drug chemical structure can be associated with toxicity level and the temporal progression of spheroid damage. These insights highlight structural motifs that should be avoided or reduced to decrease hepatotoxicity risk. Future research should include analysis of liver human spheroids toxicity response to drugs co-exposures, as combined exposures may lead to different toxicity profiles comparing to toxicity profile of single compound.en_US
dc.description.sponsorshipEuropean Union’s Horizon Europe research and innovation programme under grant agreement No. 101138387 (TOXBOX). The Ministry of Science, Technological Development and Innovation of the Republic of Serbia, contract numbers 451-03-34/2026-03/200108 (Faculty of Mechanical and Civil Engineering in Kraljevo, University of Kragujevac), 45103-33/2026-03/200378 (Institute for Information Technologies Kragujevac, University of Kragujevac) and 451-03-33/2026-03/200107 (Faculty of Engineering, University of Kragujevac).en_US
dc.language.isoenen_US
dc.publisherDepartment of Catalysis and Chemical Reaction Engineering, National Institute of Chemistry, Ljubljana, Sloveniaen_US
dc.subjectDrug safetyen_US
dc.subjectHepatotoxicityen_US
dc.subjectMachine learningen_US
dc.subjectSSbDen_US
dc.subjectQSAR Toolboxen_US
dc.titleLinking Chemical Structure to Spheroid Phenotypes: An Interpretable QSAR Approach for Hepatotoxicity in the Context of SSBDen_US
dc.typeconferenceObjecten_US
dc.description.versionPublisheden_US
dc.type.versionPublishedVersionen_US
dc.source.conferenceBiopartitioning and Purification Conference (BPP 2026), 06-09 September 2026, Bled, Sloveniaen_US
Appears in Collections:Faculty of Mechanical and Civil Engineering, Kraljevo


Files in This Item:
File SizeFormat 
BPP2026_Nikolic_M.pdf244.99 kBAdobe PDFView/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.